European Journal of Dermatology

, Volume 28, Issue 5, pp 637–643 | Cite as

Clinical characteristics and genetic variation in atopic dermatitis patients with and without allergic contact dermatitis

  • Solam Lee
  • Hye-young Wang
  • Eunjung Kim
  • Hyun Jee Hwang
  • Eunhee Choi
  • Hyeyoung Lee
  • Eung Ho ChoiEmail author
Clinical report



In patients with atopic dermatitis (AD), the risk of contact sensitization may be higher as the disrupted skin barrier may increase the penetration of contact allergens. Therefore, it is necessary to screen for concurrent allergic contact dermatitis (ACD) in AD patients.


To identify the clinical characteristics and genetic variation in AD patients with concurrent ACD.

Materials & methods

In total, 281 AD subjects who underwent patch testing were included. Subjects with a positive result were classified as “AD with ACD”, while the others were classified as “AD only”. Clinical characteristics and prevalence of genetic variants (FLG 3321delA, FLG K4022X, KLK7, SPINK5, DEFB1, KDR, IL5RA, IL9, and IL12RB1) were compared between the two groups.


Seventy-one subjects (25.3%) were found to have AD and ACD. Female sex, older age, late onset, self-reported personal or family history ofACD, and presence of prurigo nodularis were associated with concurrent ACD in AD patients. Age was useful for predicting concurrent ACD based on the receiver operating characteristic curve. However, no differences in the frequency of genetic variants were identified between the two groups.


A personal or family history of ACD, late onset, and prurigo nodularis support a suspicion of concurrentACD, although these correlations were less apparent after correcting for age and sex. Patch testing for AD in males >20 years and females >14 years may aid diagnosis of concurrent ACD with high sensitivity and specificity.

Key words

allergic contact dermatitis atopic dermatitis comorbidity contact sensitization genetic difference skin barrier 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Lee HJ, Lee NR, Jung M, Kim DH, Choi EH. Atopic march from atopic dermatitis to asthma–like lesions in NC/Nga mice is accelerated or aggravated by neutralization of stratum corneum but partially inhibited by acidification. J Invest Dermatol 2015; 135: 3025–33.CrossRefGoogle Scholar
  2. 2.
    Elias PM, Schmuth M. Abnormal skin barrier in the etiopathogenesis of atopic dermatitis. Curr Allergy Asthma Rep 2009; 9: 265–72.CrossRefGoogle Scholar
  3. 3.
    Saint–Mezard P, Rosieres A, Krasteva M, et al. Allergic contact dermatitis. Eur J Dermatol 2004; 14: 284–95.Google Scholar
  4. 4.
    Kim D, Lee NR, Park SY, et al. As in atopic dermatitis, nonlesional skin in allergic contact dermatitis displays abnormalities in barrier function and ceramide content. J Invest Dermatol 2017; 137: 748–50.CrossRefGoogle Scholar
  5. 5.
    Thyssen JP, Kezic S. Causes of epidermal filaggrin reduction and their role in the pathogenesis of atopic dermatitis. J Allergy Clin Immunol 2014; 134: 792–9.CrossRefGoogle Scholar
  6. 6.
    Jakasa I, de Jongh CM, Verberk MM, Bos JD, Kezic S. Percutaneous penetration of sodium lauryl sulphate is increased in uninvolved skin of patients with atopic dermatitis compared with control subjects. Br J Dermatol 2006; 155: 104–9.CrossRefGoogle Scholar
  7. 7.
    Halling–Overgaard AS, Kezic S, Jakasa I, Engebretsen KA, Maibach H, Thyssen JP. Skin absorption through atopic dermatitis skin: a systematic review. Br J Dermatol 2017; 177: 84–106.CrossRefGoogle Scholar
  8. 8.
    Thyssen JP, Linneberg A, Ross–Hansen K, et al. Filaggrin mutations are strongly associated with contact sensitization in individuals with dermatitis. Contact Dermatitis 2013; 68: 273–6.CrossRefGoogle Scholar
  9. 9.
    Kawasaki H, Nagao K, Kubo A, et al. Altered stratum corneum barrier and enhanced percutaneous immune responses in filaggrin–null mice. J Allergy Clin Immunol 2012; 129: 1538–46.CrossRefGoogle Scholar
  10. 10.
    Landeck L, Visser M, Skudlik C, Brans R, Kezic S, John SM. No remarkable differences in rates of sensitization to common type I and IV allergens between FLG loss–of–function mutation carriers and wild–type subjects. Contact Dermatitis 2014; 70: 27–34.CrossRefGoogle Scholar
  11. 11.
    Ross–Hansen K, Johansen JD, Volund A, Menne T, Thyssen JP. The nickel dose–response relationship by filaggrin genotype (FLG). Contact Dermatitis 2014; 71: 49–53.CrossRefGoogle Scholar
  12. 12.
    Uehara M, Sawai T. A longitudinal study of contact sensitivity in patients with atopic dermatitis. Arch Dermatol 1989; 125: 366–8.CrossRefGoogle Scholar
  13. 13.
    Hamann CR, Hamann D, Egeberg A, Johansen JD, Silverberg J, Thyssen JP. Association between atopic dermatitis and contact sensitization: a systematic review and meta–analysis. J Am Acad Dermatol 2017; 77: 70–8.CrossRefGoogle Scholar
  14. 14.
    Yoon NY, Wang HY, Jun M, et al. Simultaneous detection of barrier–and immune–related gene variations in patients with atopic dermatitis by reverse blot hybridization assay. Clin Exp Dermatol 2018; 43: 430–6.CrossRefGoogle Scholar
  15. 15.
    Barker JN, Palmer CN, Zhao Y, et al. Null mutations in the filaggrin gene (FLG) determine major susceptibility to early–onset atopic dermatitis that persists into adulthood. J Invest Dermatol 2007; 127: 564–7.CrossRefGoogle Scholar
  16. 16.
    Hubiche T, Ged C, Benard A, et al. Analysis of SPINK 5, KLK 7 and FLG genotypes in a French atopic dermatitis cohort. Acta Derm Venereol 2007; 87: 499–505.CrossRefGoogle Scholar
  17. 17.
    Vasilopoulos Y, Cork MJ, Murphy R, et al. Genetic association between an AACC insertion in the 3’UTR of the stratum corneum chymotryptic enzyme gene and atopic dermatitis. J Invest Dermatol 2004; 123: 62–6.CrossRefGoogle Scholar
  18. 18.
    Park HW, Shin ES, Lee JE, et al. Multilocus analysis of atopy in Korean children using multifactor–dimensionality reduction. Thorax 2007; 62: 265–9.CrossRefGoogle Scholar
  19. 19.
    Kim E, Lee JE, Namkung JH, et al. Single nucleotide polymorphisms and the haplotype in the DEFB1 gene are associated with atopic dermatitis in a Korean population. J Dermatol Sci 2009; 54: 25–30.CrossRefGoogle Scholar
  20. 20.
    Jurevic RJ, Bai M, Chadwick RB, White TC, Dale BA. Single–nucleotide polymorphisms (SNPs) in human beta–defensin 1: high–throughput SNP assays and association with Candida carriage in type I diabetics and nondiabetic controls. J Clin Microbiol 2003; 41: 90–6.CrossRefGoogle Scholar
  21. 21.
    Wright RJ, Finn P, Contreras JP, et al. Chronic caregiver stress and IgE expression, allergen–induced proliferation, and cytokine profiles in a birth cohort predisposed to atopy. J Allergy Clin Immunol 2004; 113: 1051–7.CrossRefGoogle Scholar
  22. 22.
    Namkung JH, Lee JE, Kim E, et al. IL–5 and IL–5 receptor alpha polymorphisms are associated with atopic dermatitis in Koreans. Allergy 2007; 62: 934–42.CrossRefGoogle Scholar
  23. 23.
    Namkung JH, Lee JE, Kim E, et al. An association between IL–9 and IL–9 receptor gene polymorphisms and atopic dermatitis in a Korean population. J Dermatol Sci 2011; 62: 16–21.Google Scholar
  24. 24.
    Lee SY, Yu J, Ahn KM, et al. Additive effect between IL–13 polymorphism and Cesarean section delivery/prenatal antibiotics use on atopic dermatitis: a birth cohort study (COCOA). PLoS One 2014; 9: e96603.CrossRefGoogle Scholar
  25. 25.
    Park BL, Kim LH, Choi YH, et al. Interleukin 3 (IL3) polymorphisms associated with decreased risk of asthma and atopy. J Hum Genet 2004; 49: 517–27.CrossRefGoogle Scholar
  26. 26.
    Namkung JH, Lee JE, Kim E, et al. Association of polymorphisms in genes encoding IL–4, IL–13 and their receptors with atopic dermatitis in a Korean population. Exp Dermatol 2011; 20: 915–9.CrossRefGoogle Scholar
  27. 27.
    Kim E, Lee JE, Namkung JH, et al. Association of the singlenucleotide polymorphism and haplotype of the interleukin 18 gene with atopic dermatitis in Koreans. Clin Exp Allergy 2007; 37: 865–71.CrossRefGoogle Scholar
  28. 28.
    Palmer CN, Irvine AD, Terron–Kwiatkowski A, et al. Common loss–of–function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006; 38: 441–6.CrossRefGoogle Scholar
  29. 29.
    Park KY, Li K, Seok J, Seo SJ. An analysis of the filaggrin gene polymorphism in korean atopic dermatitis patients. J Korean Med Sci 2016; 31: 1136–42.CrossRefGoogle Scholar
  30. 30.
    Thyssen JP, McFadden JP, Kimber I. The multiple factors affecting the association between atopic dermatitis and contact sensitization. Allergy 2014; 69: 28–36.CrossRefGoogle Scholar

Copyright information

© John Libbey Eurotext 2018

Authors and Affiliations

  • Solam Lee
    • 1
  • Hye-young Wang
    • 2
  • Eunjung Kim
    • 1
  • Hyun Jee Hwang
    • 1
  • Eunhee Choi
    • 3
  • Hyeyoung Lee
    • 4
  • Eung Ho Choi
    • 1
    Email author
  1. 1.Department of DermatologyYonsei University Wonju College of MedicineWonjuKorea
  2. 2.Optipharm, Inc.Wonju Eco Environmental Technology CenterWonjuKorea
  3. 3.Institute of Lifestyle MedicineYonsei University Wonju College of MedicineWonjuKorea
  4. 4.Department of Biomedical Laboratory ScienceYonsei UniversityWonjuKorea

Personalised recommendations